Cambridge, MA, United States
Millennium Pharmaceuticals Inc. recalls
1 recall recorded since 2018, most recently on 30 January 2018. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 30 January 2018
- Terminated
- 12 December 2018
- Reason
- Defective Container: Confirmed reports of loose vial crimps.
- Distribution
- Distributed nationwide. They estimate 4% of the product may be recovered.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0425-2018
- VELCADE (bortezomib) for injection, 3.5 mg/vial, Reconstitution Information, SUBCUTANEOUS INJECTION ONLY add 1.4 mL 0.9% Sodium Chloride to make 2.5 mg/ mL final concentration, INTRAVENOUS INJECTION ONLY add 3.5 mL Sodiu
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.